≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_PANCREAS_ADENO_EXALLC for full statistics.

Adenocarcinoma of pancreas

EFO Endpoint Browser

C3_PANCREAS_ADENO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C25
  • Cancer registry: Morphology ICD-O-3 — 8140
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

940

4. Check minimum number of events

None

940

5. Include endpoints

None

940

6. Filter based on genotype QC (FinnGen only)

940

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF8

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma of pancreas based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 940 394 546
Unadjusted period prevalence (%) 0.20 0.13 0.24
Median age at first event (years) 70.32 69.90 70.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
861
Matched controls
8610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
39.0
323.0
590
455
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
199.3
323.0
374
33
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
383.1
323.0
537
37
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
323.0
581
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
69.1
258.9
294
64
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
127.7
255.1
266
30
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
41.4
241.8
306
113
A04AA02
ATC
granisetron; systemic, transdermal
21.3
205.4
321
234
A03FA01
ATC
metoclopramide; systemic, rectal
10.0
197.9
519
1133
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
+∞
177.4
164
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
22.8
173.1
260
160
JLC30
NOMESCO Finland
Pancreatoduodenectomy
181.3
170.7
174
12
N02AA05
ATC
oxycodone; systemic
9.0
168.4
444
910
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
196.1
157.6
160
10
Z51.5
ICD-10 Finland
Palliative care
12.9
152.9
297
338
H02AB02
ATC
dexamethasone; systemic
9.7
139.1
322
500
UJK02
NOMESCO Finland
ERCP
24.1
134.3
196
104
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
64.1
129.1
149
28
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
17.6
123.5
202
147
K83.1
ICD-10 Finland
Obstruction of bile duct
46.7
123.4
151
39
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
206.5
122.0
124
7
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
21.7
120.1
181
104
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
32.3
117.7
157
59
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
73.6
111.4
126
20
L01BC06
ATC
capecitabine; oral
16.1
107.1
181
140
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
25.6
86.1
122
55
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
226.2
80.8
82
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
22.5
74.1
109
55
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
25.9
73.1
103
45
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.3
72.4
160
206
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
12.3
71.1
134
127
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.2
68.9
166
245
8140/3-C25.2
ICD-O-3
Adenocarcinoma, NOS, of tail of pancreas
+∞
66.5
63
*
D76
ICPC
Malignant neoplasm pancreas
115.1
59.7
64
6
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
18.1
59.4
94
58
A04AA01
ATC
ondansetron; systemic, rectal
7.1
59.1
156
261
JN4BD
NOMESCO Finland
Extensive body CT
4.7
57.7
223
590
JDE00
NOMESCO Finland
Gastrojejunostomy
92.1
54.6
60
7
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
31.1
51.8
69
24
JN4CD
NOMESCO Finland
Very extensive body CT
8.0
51.6
123
175
R4190
NOMESCO Finland
Nutritional therapy
11.2
50.7
99
99
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.4
49.7
96
94
8140/3-C25.1
ICD-O-3
Adenocarcinoma, NOS, of body of pancreas
+∞
49.5
47
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
135.3
48.3
51
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
44.3
47.2
58
14
JAH01
NOMESCO Finland
Laparoscopy
8.8
45.3
101
128
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
7.8
45.2
109
157
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
45.0
355
1634
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
22.6
44.7
65
31
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
13.3
43.8
78
64
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
121.3
43.2
46
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
42.3
202
633
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.4
40.6
130
272
A98
ICPC
Health maint/preventive medicine
0.4
40.1
478
6660
C25
ICD-10 Finland
Malignant neoplasm of pancreas
209.5
39.2
40
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
19.1
38.5
59
33
A06AH03
ATC
naloxegol; oral
15.8
37.7
62
42
WZC30
NOMESCO Finland
Teaching
3.6
36.7
189
624
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
8.1
36.2
84
113
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
22.1
35.7
52
25
K83.0
ICD-10 Finland
Cholangitis
13.2
35.5
63
51
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
48.9
35.0
42
9
JLC10
NOMESCO Finland
Distal pancreatectomy
67.9
34.3
39
6
JN4AD
NOMESCO Finland
Body CT examination
4.3
34.0
139
373
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.4
32.7
90
155
L03AA02
ATC
filgrastim; parenteral
8.0
31.8
74
100
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.2
31.7
130
349
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
12.6
31.6
57
48
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
31.5
111
256
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
31.4
163
536
JMA10
NOMESCO Finland
Transabdominal total splenectomy
34.9
31.2
40
12
R50.9
ICD-10 Finland
Fever, unspecified
3.1
29.9
187
704
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
38.6
29.5
37
10
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
20.1
29.4
44
23
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
21.5
28.1
41
20
B01AB10
ATC
tinzaparin; parenteral
4.1
27.8
116
315
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
27.5
135
422
191
Kela drug reimbursment
Erlotinib
55.3
27.3
32
6
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
25.7
26.8
37
15
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
23.3
26.7
38
17
R18
ICD-10 Finland
Ascites
9.0
26.7
57
67
JAH00
NOMESCO Finland
Laparotomy
6.2
24.4
67
115
L01XE03
ATC
[U] erlotinib; oral
57.8
24.2
28
5
A10AE04
ATC
insulin glargine; parenteral
3.2
24.0
139
490
WW500
NOMESCO Finland
Blood transfusion
4.9
23.0
78
172
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.4
22.6
86
213
B01AB05
ATC
enoxaparin; parenteral
2.1
22.3
326
1902
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
21.5
161
667
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
20.9
20
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
42.8
20.5
25
6
J01MA12
ATC
levofloxacin; systemic
2.3
20.1
225
1154
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
16.9
19.8
31
19
A04AA55
ATC
palonosetron, combinations; systemic
6.3
19.7
53
89
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
19.7
228
1188
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
204.5
19.6
20
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
19.6
103
337
1570A
ICD-9 Finland
Malignant neoplasm of pancreas, Head of pancreas
71.5
18.8
21
*
WX004
NOMESCO Finland
Patient-controlled sedation
30.8
18.4
24
8
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
25.7
18.3
25
10
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
6.8
17.9
45
69
JLA10
NOMESCO Finland
Biopsy of pancreas
+∞
17.8
17
*
JLA00
NOMESCO Finland
Exploration of pancreas
+∞
17.8
17
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
17.7
402
2719
A06AD11
ATC
lactulose; oral
2.2
16.9
200
1040
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
20.5
16.5
24
12
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
8.2
15.9
35
44
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
15.6
157
757
ZX122
NOMESCO Finland
Intra-arterial
18.8
14.7
22
12
N02AA01
ATC
morphine; systemic, rectal
6.9
14.6
36
54
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.6
14.5
42
78
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
14.4
53
128
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
14.0
121
537
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
30.6
13.9
18
6
1CD01
NOMESCO Finland
NA
17.9
13.9
21
12
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
13.9
13.8
23
17
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
76.4
13.6
15
*
A02BC02
ATC
pantoprazole; systemic
1.7
13.6
559
4428
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
142.2
13.5
14
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.4
13.3
87
1730
A04AD12
ATC
aprepitant; systemic
8.1
13.2
29
37
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
13.1
72
243
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
13.1
291
1902
L03AA13
ATC
pegfilgrastim; parenteral
4.2
13.0
50
126
TJA10
NOMESCO Finland
Laparocentesis
28.9
13.0
17
6
SPAT1109
SPAT
Analgesia with portable analgesic pump
10.7
12.8
24
23
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.7
12.7
55
155
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
12.6
71
244
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.5
12.5
99
1852
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
12.4
272
3810
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
12.3
228
3335
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
12.3
152
2478
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.4
12.1
77
1550
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
11.9
280
1850
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
47.4
11.9
14
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.3
11.8
37
981
K86.1
ICD-10 Finland
Other chronic pancreatitis
8.3
11.6
25
31
N06DX01
ATC
memantine; oral
0.1
11.5
6
443
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
12.0
11.4
20
17
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
35.5
11.3
14
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.8
11.3
31
55
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
25.4
11.2
15
6
C10AA05
ATC
atorvastatin; oral
0.6
11.0
178
2717
P20
ICPC
Memory disturbance
0.3
11.0
30
849
Z01.2
ICD-10 Finland
Dental examination
0.5
10.9
110
1918
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.0
10.8
29
50
M79.6
ICD-10 Finland
Pain in limb
0.5
10.8
114
1957
N05AD01
ATC
haloperidol; systemic
3.5
10.7
49
145
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.8
10.6
29
51
SPAT1053
SPAT
Memory test
0.4
10.6
51
1141
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
10.5
76
306
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
7.8
10.4
23
30
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
33.0
10.3
13
*
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
10.1
123
2034
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.5
10.1
109
1866
A41.8
ICD-10 Finland
Other specified sepsis
4.8
10.0
32
68
B01AB04
ATC
dalteparin; parenteral
2.8
10.0
64
241
C10AA07
ATC
rosuvastatin; oral
0.5
10.0
76
1450
ZX121
NOMESCO Finland
Central venous catheter
16.9
9.9
15
9
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
9.8
170
2570
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
26.4
9.8
13
5
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.5
9.7
107
1827
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
55.6
9.7
11
*
G04BD12
ATC
mirabegron; oral
0.3
9.6
17
597
K85.8
ICD-10 Finland
Other acute pancreatitis
7.3
9.5
22
31
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
9.5
33
841
WX320
NOMESCO Finland
Spinalanesthesy
0.5
9.5
65
1283
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.2
9.5
28
55
JKD00
NOMESCO Finland
Anastomosis of gallbladder to jejunum
101.1
9.4
10
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
30.4
9.4
12
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
9.4
203
2915
XKD00
NOMESCO Finland
Uroflowmetry
0.5
9.2
59
1191
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
9.2
160
948
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
9.2
108
1809
WX002
NOMESCO Finland
Sedation and analgesia
1.8
9.1
181
1122
K02.1
ICD-10 Finland
Caries of dentine
0.6
9.1
197
2832
N40
ICD-10 Finland
Hyperplasia of prostate
0.5
9.0
111
1842
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
9.0
190
2751
ZX120
NOMESCO Finland
Intravenous
2.1
9.0
98
486
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
24.3
8.9
12
5
A79
ICPC
Malignancy NOS
5.2
8.8
26
51
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.2
8.8
12
481
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
8.8
107
556
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.3
8.7
21
632
R83
ICPC
Respiratory infection other
0.3
8.6
23
659
M25.5
ICD-10 Finland
Pain in joint
0.5
8.4
72
1326
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
9.6
8.3
16
17
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.6
8.2
123
1941
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
33.7
8.1
10
*
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
33.7
8.1
10
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.0
8.0
21
36
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
8.0
371
4593
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.0
100
1654
F03
ICD-10 Finland
Unspecified dementia
0.1
7.9
*
302
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
7.9
38
119
L57.0
ICD-10 Finland
Actinic keratosis
0.3
7.9
23
635
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
7.9
8
381
DFF00
NOMESCO Finland
Pure tone audiometry
0.3
7.8
15
501
JKA20
NOMESCO Finland
Cholecystectomy
3.2
7.8
39
126
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
7.8
57
1107
B01AC04
ATC
clopidogrel; oral
0.5
7.8
59
1131
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
7.7
101
1656
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
7.7
189
2668
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
25.3
7.6
10
*
TPX15
NOMESCO Finland
Removal of vascular injection port
9.0
7.6
15
17
I81
ICD-10 Finland
Portal vein thrombosis
10.1
7.5
14
14
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.6
7.5
171
2452
207
Kela drug reimbursment
Chronic arrhythmias
0.5
7.5
51
1012
R5140
NOMESCO Finland
Monitoring the use of the aid
0.3
7.4
14
475
XCW99
NOMESCO Finland
Other investigative procedure of eye
0.4
7.4
25
644
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.4
7.4
41
873
AA1AD
NOMESCO Finland
CT of head and brain
0.6
7.4
92
1529
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
7.4
34
778
B01AF02
ATC
apixaban; oral
0.4
7.4
22
597
1571A
ICD-9 Finland
Malignant neoplasm of pancreas, Body of pancreas
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
9.5
7.3
14
15
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
0.6
7.3
145
2146
R06.0
ICD-10 Finland
Dyspnoea
0.6
7.2
101
1631
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.2
208
1421
R03AC02
ATC
salbutamol; inhalant
0.7
7.2
230
3082
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.4
7.2
28
682
K31.5
ICD-10 Finland
Obstruction of duodenum
30.3
7.2
9
*
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
30.3
7.2
9
*
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
7.1
28
75
R42
ICD-10 Finland
Dizziness and giddiness
0.5
7.1
82
1388
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.4
6.9
36
789
L15
ICPC
Knee symptom/complaint
0.5
6.8
58
1075
ZXA05
NOMESCO Finland
Left side
0.6
6.8
106
1667
C10AX09
ATC
ezetimibe; oral
0.3
6.8
19
535
M01AH05
ATC
etoricoxib; oral
0.7
6.8
251
3281
R05
ICD-10 Finland
Cough
0.5
6.7
52
992
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.0
6.7
25
64
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
6.6
98
1559
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.4
6.6
35
757
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.1
6.5
19
38
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.5
6.5
28
82
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.4
6.4
32
711
J01CA04
ATC
amoxicillin; systemic
0.7
6.4
433
5106
6706
FHL
Pancreatic homeectomy (eg Whipple)
70.4
6.4
7
*
DFF15
NOMESCO Finland
Speech audiometry
0.1
6.4
*
242
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
6.4
66
1158
R53
ICD-10 Finland
Malaise and fatigue
0.5
6.4
73
1248
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.2
6.4
6
299
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.3
228
1641
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
11.1
6.3
11
10
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
6.3
76
1279
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
6.3
77
403
N07BC02
ATC
methadone; systemic
18.2
6.3
9
5
JFC00
NOMESCO Finland
Entero-enterostomy
18.2
6.3
9
5
PHC71
NOMESCO Finland
Suture of mesenteric or portal vein
+∞
6.3
6
*
6672
FHL
Cholecocenterostomy
+∞
6.3
6
*
1579X
ICD-9 Finland
Malignant neoplasm of pancreas, Pancreas, part unspecified
+∞
6.3
6
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
26.9
6.2
8
*
C07AB07
ATC
bisoprolol; oral
0.7
6.2
288
3632
L13
ICPC
Hip symptom/complaint
0.5
6.2
45
876
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
5.4
6.2
17
32
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.3
6.1
16
461
M48.0
ICD-10 Finland
Spinal stenosis
0.5
6.1
38
778
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
6.1
156
2199
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.9
6.1
35
125

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
319
329
14.16
293.17
7.8
3.1
u/ml
35479.7
1153.9
1.09
291
274
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
489
902
10.22
287.74
7.3
4.1
ug/l
142.6
22.4
1.20
468
767
(3000570) Elastase.pancreatic [Mass/mass] in Stool
249
219
15.11
251.06
1.6
1.4
ug/g
143.4
275.4
13.38
134
129
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
223
162
17.74
250.84
8.1
3.3
u/ml
7696.8
765.8
2.56
213
152
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
105
65
18.06
126.08
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
259
755
4.35
80.85
4.0
2.1
g/l
0.2
0.2
4.85
245
698
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
278
866
4.14
79.11
5.9
2.7
umol/l
41.9
9.3
13.02
255
762
(40768441) Liver Pathology biopsy report
69
53
13.97
73.19
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
445
7003
0.31
69.00
3.5
5.4
mmol/l
2.6
2.6
0.27
368
6275
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
415
6753
0.31
67.97
3.3
4.7
mmol/l
1.4
1.4
3.15
338
6038
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
425
6819
0.31
67.13
3.2
4.8
mmol/l
4.5
4.5
0.08
345
6151
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
478
2387
3.04
61.08
6.0
2.5
u/l
45.9
56.9
5.16
457
2179
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
412
6520
0.34
55.79
3.1
4.2
mmol/l
1.3
1.3
1.01
337
5782
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
465
6908
0.35
53.37
3.8
5.1
mmol/l
7.0
6.1
12.61
397
6129
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
408
6375
0.36
50.06
3.4
4.7
mu/l
2.1
2.2
0.20
332
5672
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
455
6676
0.38
45.37
6.9
6.5
mmol/mol
45.8
40.9
12.12
408
6065
(3000963) Hemoglobin [Mass/volume] in Blood
582
7623
0.38
42.65
54.2
25.4
g/l
116.6
132.8
111.90
561
7462
(3010813) Leukocytes [#/volume] in Blood
582
7622
0.38
42.59
53.7
25.3
e9/l
8.0
6.9
14.36
553
7350
(3026361) Erythrocytes [#/volume] in Blood
582
7620
0.38
42.47
53.7
25.3
e12/l
3.9
4.4
72.38
555
7348
(3035941) MCH [Entitic mass]
582
7619
0.38
42.41
53.5
25.2
pg
30.1
30.5
6.20
564
7460
(3024731) MCV [Entitic volume]
582
7619
0.38
42.41
53.6
25.2
fl
91.3
91.8
1.71
564
7462
(3007461) Platelets [#/volume] in Blood
582
7619
0.38
42.41
53.8
25.3
e9/l
262.5
239.1
8.35
558
7381
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
309
5208
0.39
38.88
2.9
3.8
pmol/l
14.9
15.0
0.47
254
4608
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
184
707
2.99
35.10
9.0
2.2
u/l
46.5
32.5
1.02
169
586
(3023103) Potassium [Moles/volume] in Serum or Plasma
578
7450
0.42
34.71
41.4
20.8
mmol/l
4.0
4.0
5.01
557
7230
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
472
6570
0.43
34.08
40.9
16.3
ml/min/173m2
83.4
72.8
22.42
421
5464
(3019550) Sodium [Moles/volume] in Serum or Plasma
578
7433
0.42
33.85
41.4
20.7
mmol/l
137.3
139.6
47.02
557
7219
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
574
7397
0.42
33.62
29.8
11.2
u/l
44.5
24.8
23.45
555
7064
(3023368) Bacteria identified in Blood by Culture
419
2439
2.30
33.18
7.4
4.4
—
—
—
0
0
(4035726)
167
673
2.80
28.81
1.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
560
7176
0.46
28.64
34.0
16.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
366
5377
0.48
26.04
3.0
4.2
mm/h
19.5
14.4
5.37
327
4882
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
369
2222
2.09
25.04
6.6
3.2
u/l
63.6
34.4
10.16
355
2111
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
65
1918
0.29
22.70
1.4
1.6
mmol/l
1.5
1.3
0.30
60
1566
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
554
4066
1.88
19.39
26.7
6.2
umol/l
22.6
12.2
6.71
538
3846
(3044889) 12 lead EKG panel
380
5253
0.54
18.80
4.1
4.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
497
3548
1.85
18.75
13.2
4.7
g/l
30.4
34.7
44.10
480
3286
(3003338) MCHC [Mass/volume]
411
5536
0.54
18.40
50.1
23.2
g/l
328.8
331.3
7.54
405
5484
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
132
2579
0.43
18.11
3.7
4.7
%
21.4
21.6
0.06
56
1338
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
577
7024
0.54
17.86
40.9
17.3
mg/l
43.3
27.1
17.57
556
5751
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
189
3208
0.49
17.44
3.6
5.5
ug/l
3.0
3.4
0.23
143
2820
(3009542) Hematocrit [Volume Fraction] of Blood
467
6024
0.55
17.38
39.5
19.1
%
34.4
38.6
13.11
275
3725
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
127
2467
0.44
16.90
1.9
2.1
u/l
135.8
250.3
1.45
115
2300
(3012095) Magnesium [Moles/volume] in Serum or Plasma
223
1277
1.98
16.23
3.6
3.3
mmol/l
0.8
0.8
0.77
209
1187
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
205
3315
0.51
15.86
2.3
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
84
326
2.73
15.27
2.4
2.4
u/ml
0.3
0.4
1.41
52
191
(3032080) INR in Blood by Coagulation assay
478
3515
1.73
15.06
10.4
11.1
inr
1.2
1.3
1.67
136
950
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
226
3489
0.54
14.66
2.1
2.1
pmol/l
96.1
93.8
0.26
135
1786
(3033658) Prothrombin time (PT) actual/Normal
295
1902
1.80
14.64
7.5
4.0
%
76.9
85.1
7.60
289
1854
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
261
1649
1.81
13.72
10.9
3.1
mmol/l
2.5
2.5
7.01
253
1435
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
172
2830
0.52
13.42
2.1
3.2
ng/l
1600.9
1844.2
0.27
155
2456
(3002385) Erythrocyte distribution width [Ratio]
440
5602
0.60
13.36
49.4
21.2
%
15.3
13.9
41.97
431
5462
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
190
2994
0.54
12.65
2.2
2.2
nmol/l
67.3
78.6
6.10
172
2592
(3044640) Blood type and Crossmatch panel - Blood
352
2470
1.68
12.51
3.5
2.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
90
4.00
12.36
1.4
1.6
g/l
0.9
0.8
0.11
23
74
(3026493) Urate [Moles/volume] in Serum or Plasma
111
2045
0.48
11.95
2.4
2.9
umol/l
342.3
7981.6
8.45
82
1726
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
96
1837
0.47
11.44
2.6
3.3
ug/l
0.6
0.8
3.80
61
1304
(3042936) Bacteria identified in Isolate by Culture
198
1223
1.78
10.94
2.1
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
153
2450
0.55
10.25
2.5
3.3
mg/l
172.5
294.2
0.54
89
1574
(1761868) Lipid panel - Serum or Plasma
115
1997
0.52
10.07
3.1
3.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
50
185
2.80
9.98
1.5
2.7
umol/l
38.1
33.6
0.67
34
151
(3021960) Folate [Moles/volume] in Serum or Plasma
127
2130
0.53
9.90
1.6
1.6
nmol/l
21.2
20.3
0.31
117
1789
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
48
180
2.76
9.35
1.1
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
162
2478
0.58
8.92
2.5
3.2
mmol/l
6.7
7.2
0.85
127
2023
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
1001
0.39
8.55
1.1
1.2
u/ml
21.2
13.4
0.18
15
342
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
45
4.52
8.39
1.1
1.2
g/l
3.5
2.8
1.14
11
36
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
45
4.52
8.39
1.1
1.2
g/l
0.6
0.4
0.56
11
35
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
45
4.52
8.39
1.1
1.2
g/l
6.2
7.5
0.68
11
35
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
113
636
1.88
8.34
1.5
1.6
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
34
5.07
8.16
1.1
2.2
e6/l
2617.4
607.7
0.52
12
27
(4062490)
20
47
4.33
7.96
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
178
2596
0.61
7.89
3.4
4.0
mg/mmol
27.1
9.1
1.31
98
1652
(3012501) Base excess in Blood by calculation
46
185
2.56
7.85
4.7
4.9
mmol/l
2.6
2.9
0.33
35
126
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
25
5.67
7.56
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
1049
0.45
7.38
1.1
1.2
iu/ml
56.8
41.8
0.26
13
333
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
999
0.44
7.17
10.7
8.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
1697
0.57
6.84
3.7
4.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
498
4144
1.43
6.68
27.1
8.7
e9/l
4.7
4.2
3.05
467
3609
(3001122) Ferritin [Mass/volume] in Serum or Plasma
222
2993
0.66
6.60
2.3
2.8
ug/l
295.0
154.4
4.68
202
2698
(3019150) Specific gravity of Urine by Refractometry
98
1596
0.57
6.54
3.7
4.6
kg/l
1.0
1.0
0.39
17
239
(3017446) Testosterone [Moles/volume] in Serum or Plasma
14
503
0.27
6.47
1.7
2.2
nmol/l
11.6
12.1
0.07
14
436
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
24
650
0.35
6.46
3.6
3.9
ng/l
137.6
94.4
1.00
18
563
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
22
5.51
6.30
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
22
5.51
6.30
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
24
641
0.36
6.27
1.7
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
275
3529
0.69
6.22
4.7
5.5
estimate
0.0
0.0
0.00
80
658
(3035350) Ketones [Presence] in Urine by Test strip
276
3534
0.69
6.14
3.5
4.1
estimate
0.0
0.0
0.00
80
661
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
252
1873
1.47
6.10
3.2
2.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
118
2.68
5.95
3.9
3.0
%
60.4
59.7
0.11
31
118
(3009261) Glucose [Presence] in Urine by Test strip
282
3579
0.70
5.90
3.5
4.1
estimate
0.0
0.0
0.50
75
648
(3015377) Calcium [Moles/volume] in Serum or Plasma
347
2762
1.41
5.72
10.7
3.5
mmol/l
2.3
2.3
6.17
330
2355
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
21
5.29
5.53
1.2
4.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
13
29
4.53
5.52
1.1
2.2
e6/l
677.3
64479.8
—
7
17
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
70
391
1.85
5.32
1.7
1.9
ug/l
3.3
2.0
0.27
64
340
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
998
0.52
5.27
3.6
4.8
%
33.3
32.7
0.12
34
633
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
418
3472
1.37
5.19
5.8
4.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
12
27
4.49
5.04
1.1
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
226
1706
1.43
4.92
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
46
232
2.03
4.72
4.7
4.5
ph
7.4
7.4
0.20
46
181
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
48
247
1.99
4.67
2.2
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
12
29
4.18
4.63
1.1
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
45
827
0.52
4.49
1.2
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
153
1093
1.48
4.43
2.8
5.6
mmol/l
1.0
1.0
0.40
140
1002
(3000492) Spirometry study
25
562
0.43
4.42
1.2
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
112
2.45
4.42
3.1
2.6
e9/l
4.5
4.5
0.02
27
112
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
620
0.47
4.25
1.5
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
82
515
1.65
4.19
2.0
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
704
0.51
4.13
1.3
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
134
1845
0.68
4.10
1.9
1.8
nmol/l
1290.8
1183.6
0.67
110
1363
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
327
0.30
3.98
1.3
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
819
0.55
3.94
2.1
2.5
ug/l
2.2
6.6
9.47
42
703
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
18
65
2.80
3.87
1.1
1.1
nmol/l
0.9
1.5
1.38
13
58
(40761535) Cells panel - Urine sediment
39
710
0.53
3.79
3.7
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
454
5134
0.78
3.62
3.7
4.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
117
2.26
3.60
1.2
1.3
e6/l
49131.6
56605.8
0.09
16
66
(3045788) Cell count panel - Pleural fluid
24
105
2.32
3.54
1.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
28
132
2.16
3.48
1.2
1.3
e6/l
2906.4
1369.2
0.48
22
91
(21494755) Public health laboratory ask at order entry panel
9
261
0.34
3.46
1.1
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
138
1836
0.71
3.44
1.5
1.7
pmol/l
513.7
7965031.1
0.80
108
1469
(3037522) Nuclear Ab [Titer] in Serum
50
823
0.59
3.42
1.1
1.3
titre
502.9
482.5
—
7
193
(3026782) Osmolality of Urine
211
1668
1.34
3.37
3.0
3.0
mosm/kgh2o
546.6
554.1
0.18
189
1408
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
224
0.31
3.35
1.4
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
39
213
1.87
3.27
8.4
6.2
mmol/l
104.9
105.3
0.16
34
194
(3039000) Anion gap in Blood
39
213
1.87
3.27
8.4
6.1
mmol/l
10.9
11.3
0.45
34
194
(3045414) Leukocytes [Presence] in Urine
11
307
0.35
3.25
1.5
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
116
1560
0.71
3.06
1.6
1.7
mg/l
3.2
1.5
2.89
102
1226
(3013512) EKG study
198
2452
0.76
3.05
3.8
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
112
810
1.43
3.05
3.1
3.7
mmol/l
1.7
2.1
0.37
93
640
(40768443) Skin Pathology biopsy report
13
325
0.39
3.04
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
172
2171
0.75
3.03
2.0
2.2
mg/l
3.1
3.2
0.27
154
1831
(3021589) Normoblasts [#/volume] in Blood
263
3132
0.78
3.00
19.7
10.1
e9/l
0.0
0.0
0.21
208
2552
(3020779) Urea [Moles/volume] in Serum or Plasma
106
762
1.44
2.98
2.7
7.3
mmol/l
8.8
11.6
3.14
96
723
(3021447) Carbon dioxide [Partial pressure] in Venous blood
112
815
1.42
2.95
3.1
3.7
kpa
5.6
5.8
2.34
106
787
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
334
0.41
2.94
1.0
1.1
iu/ml
288.2
129.5
—
6
118
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
277
3263
0.79
2.85
3.3
4.2
ng/l
51.0
54.1
0.05
231
2513
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
23
3.94
2.78
1.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
38
632
0.58
2.73
1.4
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
473
1.52
2.70
9.1
10.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
362
0.46
2.69
1.7
2.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
45
275
1.67
2.63
8.2
6.0
mmol/l
1.5
1.3
0.49
38
245
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
228
2727
0.78
2.62
3.7
4.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
24
122
1.99
2.52
5.5
6.0
mg/l
10.9
12.1
0.75
19
111
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
116
877
1.37
2.47
6.5
3.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
88
1192
0.71
2.42
1.3
1.5
g/l
2.5
2.7
0.65
50
686
(4010399)
30
513
0.57
2.42
1.1
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
46
2.63
2.36
6.5
3.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
181
1469
1.29
2.36
1.9
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
155
0.32
2.29
1.2
1.3
—
—
—
0
0
(4281824)
16
73
2.21
2.22
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
46
692
0.65
2.21
1.3
2.0
ug/g
104.5
152.3
0.99
36
554
(3037756) Immunofixation for Serum or Plasma
9
214
0.41
2.20
1.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
42
2.64
2.19
1.3
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
42
2.64
2.19
1.3
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
216
1808
1.25
2.18
22.1
6.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
409
0.55
2.15
2.5
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
109
1.95
2.11
1.3
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
84
619
1.39
2.11
3.2
4.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
280
2422
1.22
2.08
5.7
4.0
ph
7.4
7.4
0.39
75
452
(3024354) Oxygen [Partial pressure] in Venous blood
91
682
1.37
2.07
2.7
2.9
kpa
4.5
4.4
0.28
85
657
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
89
2.04
2.07
1.3
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
176
0.39
2.04
1.1
1.2
—
21.1
—
0
9
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
675
1.37
2.04
7.0
3.8
mmol/l
1.2
1.2
0.70
80
580
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
144
0.34
2.03
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
140
1.81
2.02
1.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
130
1032
1.30
2.01
1.8
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
103
1321
0.75
2.00
1.2
1.2
u/ml
0.9
1.3
1.08
21
328
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
205
0.43
1.96
1.3
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
205
0.43
1.96
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
98
1.96
1.96
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
129
1029
1.29
1.93
1.9
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
142
0.35
1.88
1.2
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
65
2.17
1.88
1.4
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
52
0.00
1.88
0.0
1.2
—
6.0
—
0
13
(40760888) Immunoglobulin light chains.free panel - Serum
10
224
0.44
1.88
1.8
4.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
465
0.61
1.87
1.1
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
20
107
1.89
1.87
1.9
1.9
%
89.2
89.1
0.02
20
107
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
294
1.52
1.85
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
223
2586
0.82
1.85
3.0
3.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
57
789
0.70
1.81
2.0
2.6
e9/l
67.0
68.9
0.10
46
612
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
123
1.81
1.81
4.0
2.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
53
2.28
1.81
1.3
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
165
0.42
1.80
1.1
1.2
—
2.6
—
0
22
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
168
0.41
1.79
1.1
1.2
—
3.3
—
0
27
(3024263) Appearance of Synovial fluid
0
47
0.00
1.71
0.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
196
1.60
1.67
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
196
1.60
1.67
1.5
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
70
922
0.74
1.65
1.5
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
25
2.81
1.65
1.1
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
283
2501
1.19
1.63
3.2
3.5
e6/l
25.2
97.8
2.10
237
1959
(3037121) Protein [Mass/volume] in Urine
18
312
0.57
1.60
1.4
2.9
g/l
0.5
0.3
—
8
116
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
20
3.01
1.58
1.2
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
332
3671
0.85
1.56
4.2
5.6
e9/l
0.2
0.2
1.50
285
3211
(3031040) Bacteria [#/volume] in Urine by Automated count
471
5068
0.86
1.55
4.5
5.0
e6/l
11.9
2890.8
—
7
93
(3013826) Glucose [Moles/volume] in Serum or Plasma
495
4595
1.16
1.53
7.2
5.0
mmol/l
8.0
6.8
14.42
477
4326
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
201
1.56
1.53
1.2
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
183
0.49
1.52
1.6
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
184
0.48
1.51
4.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
126
0.39
1.50
1.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
38
2.38
1.46
1.2
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
95
759
1.28
1.44
4.7
7.3
mmol/l
1.6
1.4
0.52
90
727
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
66
1.98
1.44
1.5
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
258
2287
1.18
1.42
3.3
3.4
e6/l
0.7
0.5
0.53
215
1750
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
250
0.55
1.40
1.1
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
139
0.43
1.40
1.2
1.2
—
8.2
—
0
13
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
55
408
1.37
1.40
2.9
2.5
%
0.7
0.6
0.52
55
395
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
29
190
1.54
1.38
1.2
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
170
1971
0.83
1.38
3.6
4.4
estimate
0.0
0.0
0.50
69
627
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
120
0.41
1.38
1.8
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
112
1.71
1.36
1.3
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
97
1.77
1.35
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
38
0.00
1.34
0.0
1.2
—
0.3
—
0
23
(3012441) Differential panel - Pleural fluid
19
113
1.70
1.32
1.2
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
24
2.51
1.30
2.0
2.2
—
—
—
0
0
(4034850)
13
230
0.56
1.28
12.2
11.8
—
—
—
0
0
(3035880) pH of Pleural fluid
12
62
1.95
1.28
1.1
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
331
3618
0.87
1.28
4.1
5.5
e9/l
1.5
1.8
6.17
288
3167
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
204
0.53
1.27
3.9
1.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
8
35
2.30
1.27
1.0
1.2
mmol/l
7.3
3.2
—
8
29
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
252
0.59
1.23
1.3
1.5
—
95.0
—
0
12
(3019832) Treponema pallidum Ab [Presence] in Serum
10
189
0.52
1.23
1.6
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
38
522
0.72
1.22
2.1
3.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
326
3554
0.87
1.19
3.9
5.4
e9/l
0.0
0.0
0.08
273
3052
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
402
3725
1.14
1.18
6.7
6.2
mmol/l
1.2
1.2
3.99
381
3350
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
125
1.61
1.18
1.3
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
30
426
0.69
1.17
1.4
1.8
g/l
1.0
1.6
1.58
25
389
(3001604) Monocytes [#/volume] in Blood
325
3539
0.88
1.16
3.9
5.4
e9/l
0.7
0.6
1.67
271
3028
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
33
0.00
1.16
0.0
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
136
1161
1.20
1.16
1.9
2.6
%
21.4
22.1
0.20
120
993
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.1
—
10.4
—
0
9
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.2
—
38.1
—
0
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
110
1.65
1.16
1.3
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
176
1.49
1.11
2.1
2.5
%
14.3
15.8
—
7
89
(3009343) pH of Capillary blood
42
558
0.74
1.11
1.8
3.8
ph
7.5
7.4
—
6
69
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
137
0.51
1.10
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
308
2817
1.14
1.09
2.7
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
70
866
0.79
1.09
1.6
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
121
1030
1.20
1.07
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
43
566
0.75
1.07
1.8
3.7
kpa
5.0
5.2
0.75
37
527
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
531
0.74
1.06
1.8
3.8
mmol/l
2.6
2.0
0.32
28
402
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
138
1.53
1.03
1.3
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
241
2177
1.14
1.02
3.3
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
88
733
1.22
0.98
5.6
8.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
161
0.55
0.98
1.0
1.1
—
12.6
—
0
11
(40765096) Chromosome analysis panel by Banding
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
9
50
1.81
0.96
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
69
1.75
0.96
1.6
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
101
857
1.20
0.94
7.2
8.1
g/l
114.2
119.8
2.44
95
827
(3000850) Epithelial cells [#/volume] in Urine
197
1766
1.15
0.94
2.5
2.7
e6/l
7.3
4.7
1.01
180
1554
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
130
0.54
0.88
1.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
413
0.74
0.87
1.6
3.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
240
0.66
0.87
1.4
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
48
380
1.28
0.85
7.5
4.6
%
1.0
0.9
0.77
43
358
(1616796) Gas panel - Central venous blood
25
179
1.41
0.84
2.1
4.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
171
1.41
0.83
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
46
1.75
0.82
6.3
2.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
442
0.76
0.82
1.3
1.9
g/l
1.6
1.6
0.07
28
389
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
97
1.56
0.81
1.0
1.4
u/ml
111.4
103.8
—
5
12
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
48
383
1.27
0.81
7.5
4.6
%
1.8
1.6
1.08
43
361
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
428
4050
1.10
0.80
7.2
7.0
mmol/l
1.2
1.2
1.95
339
3420
(3003129) Base excess in Capillary blood by calculation
0
24
0.00
0.79
0.0
1.3
—
1.9
—
0
24
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.1
—
40.6
—
0
5
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
25
0.00
0.79
0.0
1.1
—
1.1
—
0
7
(42870588) Differential panel, method unspecified - Blood
267
2467
1.11
0.79
4.2
5.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
26
0.00
0.78
0.0
2.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
110.0
—
0
18
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
26
0.00
0.78
0.0
1.8
—
56.7
—
0
26
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
122
0.57
0.78
1.1
1.2
—
31.9
—
0
10
(40768806) Pleura Pathology biopsy report
18
123
1.47
0.78
1.3
1.6
—
—
—
0
0
(44806420)
6
34
1.77
0.76
2.2
2.3
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
34
1.77
0.76
1.5
1.1
%
38.9
25.9
—
6
29
(3036670) Protein [Mass/volume] in Synovial fluid
0
28
0.00
0.76
0.0
1.2
—
35.6
—
0
14
(3021901) Oxygen saturation in Capillary blood
10
161
0.62
0.75
1.9
2.8
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
26
193
1.36
0.74
4.6
3.5
mmol/l
9.9
7.9
2.39
26
188
(3017732) Neutrophils [#/volume] in Blood
35
444
0.78
0.72
4.2
3.2
e9/l
3.8
4.1
0.27
28
320
(3002256) Pathology report gross observation
107
940
1.16
0.70
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
58
1.56
0.70
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
145
0.62
0.70
1.8
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
27
204
1.33
0.69
4.5
3.4
mmol/l
2.0
1.6
0.43
27
199
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
87
998
0.86
0.67
1.9
4.1
u/l
255.1
254.1
0.02
81
941
(3008152) Bicarbonate [Moles/volume] in Arterial blood
69
589
1.19
0.65
7.4
6.2
mmol/l
24.5
24.5
0.01
62
555
(3045142) Bone marrow Pathology biopsy report
6
101
0.59
0.62
1.2
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
102
0.59
0.62
2.8
2.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
209
0.71
0.60
2.6
2.5
ug/min
106.6
96.5
—
10
122
(3008536) Aspergillus sp Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
22
0.00
0.59
0.0
1.3
—
0.8
—
0
16
(3020891) Body temperature
43
355
1.22
0.58
5.4
4.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
146.2
—
0
23
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
44
365
1.22
0.57
1.1
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
115
1.40
0.57
1.0
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
106
949
1.13
0.56
7.0
7.5
%
96.5
95.4
2.09
100
917
(3027945) Reticulocytes/100 erythrocytes in Blood
94
1053
0.88
0.54
1.7
2.5
%
1.9
1.8
0.30
89
939
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
38
1.58
0.54
1.7
1.2
%
0.9
3.8
—
6
30
(3019060) Gas panel - Arterial blood
72
629
1.16
0.54
5.7
4.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
61
1.48
0.53
1.3
1.5
%
12.7
10.3
—
9
61
(3019225) pH of Specimen
72
820
0.87
0.53
2.7
4.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
99
0.60
0.52
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
83
1.45
0.52
6.7
3.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
594
0.85
0.50
6.0
3.2
ml/min/173m2
62.4
58.8
0.38
24
253
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
564
5796
0.93
0.47
28.0
7.7
u/l
204.3
81.2
36.29
548
5385
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
154
0.71
0.47
1.3
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
188
0.74
0.47
1.7
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
85
1.42
0.47
1.0
1.2
nmol/l
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
81
0.62
0.46
3.0
4.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
1.4
1.8
umol/l
12.1
15.8
—
7
45
(3034770) Mitochondria Ab [Titer] in Serum
23
185
1.25
0.42
1.0
1.2
—
653.3
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
30
249
1.21
0.42
4.7
5.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
10
70
1.43
0.42
1.4
1.3
u/l
11.0
14.4
—
10
62
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
58
1.38
0.41
1.4
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
1589.1
—
0
15
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
47.2
—
0
15
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
16
0.00
0.41
0.0
1.9
—
2.9
—
0
6
(3013637) Mi-2 Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
117
1268
0.91
0.40
14.8
29.0
inr
1.1
1.4
2.87
20
165
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
149
0.74
0.40
1.3
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
114
1050
1.10
0.39
6.6
7.3
mmol/l
0.9
1.3
0.44
95
820
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
35
1.43
0.39
1.0
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.8
—
2.1
—
0
8
(3018010) Neutrophils/100 leukocytes in Blood
322
3347
0.94
0.37
4.0
5.6
%
63.2
58.5
7.12
303
3120
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
76
0.66
0.36
1.0
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
80
0.62
0.35
1.2
1.2
—
78.7
—
0
5
(3041096) Erythrocytes [Presence] in Urine by Automated
176
1863
0.93
0.35
3.2
3.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
64
576
1.12
0.35
1.2
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
113
1050
1.09
0.33
6.7
7.3
kpa
5.0
5.1
1.02
106
1011
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
655
0.89
0.33
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
188
0.79
0.33
1.1
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
113
1051
1.09
0.33
6.7
7.2
kpa
13.7
11.8
2.81
105
1012
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
88
0.68
0.33
1.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.0
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
174
1.21
0.31
1.2
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
143
1347
1.07
0.31
3.2
3.2
e6/l
3.1
2.0
0.43
86
767
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
97
0.72
0.31
1.3
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
84
1.31
0.30
1.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
554
1.11
0.30
1.3
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
47
521
0.90
0.27
1.5
2.7
g/l
10.0
11.0
0.77
36
476
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
119
0.75
0.27
1.0
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
46
414
1.12
0.27
4.0
3.9
%
51.6
48.1
0.46
46
408
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
75
0.66
0.26
1.2
1.3
iu/l
42.4
26.7
—
5
62
(3000093) Morphology [Interpretation] in Blood Narrative
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.0
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
236
1.15
0.24
5.7
3.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
153
1601
0.95
0.23
3.1
4.2
ng/l
79.4
304.7
3.55
119
1379
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
41
452
0.90
0.23
2.4
2.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
292
2836
1.04
0.23
3.6
4.0
e6/l
65.1
137.2
1.30
239
2091
(3011288) Drugs identified in Urine by Screen method
5
40
1.25
0.22
1.0
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
191
1.16
0.22
2.4
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
210
1.15
0.22
1.3
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
317
3253
0.96
0.21
4.2
5.6
%
0.6
0.6
1.81
300
3026
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
5.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
15.5
—
0
11
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
3.3
—
0.6
—
0
10
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
79.6
—
0
10
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
428
4194
1.04
0.21
5.2
3.2
u/l
267.2
54.8
19.40
401
3811
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
101
0.79
0.21
1.3
4.1
—
—
—
0
0
(4146454)
8
103
0.77
0.21
2.0
2.6
—
—
—
0
0
(4133840)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
0.5
—
0
8
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
211
1.14
0.20
1.3
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
326
3340
0.96
0.20
4.1
5.6
%
2.3
2.9
4.28
309
3098
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
99
1.21
0.19
1.0
1.1
u/ml
272.5
362.3
—
6
55
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
51
1.18
0.19
1.2
3.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
303
2956
1.04
0.19
3.3
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
40
436
0.91
0.19
4.4
4.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
214
1.12
0.17
1.3
1.2
—
—
—
0
0
(44790048)
11
91
1.21
0.17
1.1
1.6
—
—
—
0
0
(44790049)
11
91
1.21
0.17
1.1
1.6
—
—
—
0
0
(44806118)
11
91
1.21
0.17
1.1
1.6
—
—
—
0
0
(44790047)
11
91
1.21
0.17
1.1
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
62
584
1.07
0.16
1.3
1.7
%
1.8
1.6
0.73
45
468
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
216
1.11
0.15
1.8
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
99
0.81
0.13
1.5
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
138
1422
0.97
0.12
3.1
3.0
e6/l
1.4
1.1
0.55
81
838
(3019069) Monocytes/100 leukocytes in Blood
330
3354
0.98
0.12
4.2
5.9
%
8.5
8.9
0.87
312
3123
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
105
1.14
0.11
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
96
1.15
0.10
2.0
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
145
1415
1.03
0.10
3.5
4.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
271
1.07
0.10
1.7
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
39
369
1.06
0.09
1.8
1.8
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
46
1.09
0.09
1.4
1.3
u/l
28.6
20.0
—
5
39
(3025159) Blasts/100 leukocytes in Blood
53
554
0.95
0.09
2.6
4.1
%
0.0
0.6
0.53
34
155
(3002030) Lymphocytes/100 leukocytes in Blood
336
3403
0.98
0.09
4.2
5.9
%
20.4
26.0
14.56
314
3149
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
48
1.04
0.09
1.4
1.3
u/l
246.8
79.0
—
5
42
(3021440) Promyelocytes/100 leukocytes in Blood
57
594
0.96
0.09
2.5
4.1
%
0.1
0.1
0.09
39
184
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
267
0.93
0.08
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
62
0.81
0.08
2.8
2.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
62
0.81
0.08
1.0
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
64
0.78
0.08
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
64
0.78
0.08
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
65
0.77
0.08
1.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
75
0.80
0.07
1.2
2.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
80
0.87
0.07
1.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
206
1.07
0.07
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
326
0.95
0.07
2.4
3.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
403
1.04
0.07
1.2
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
11
99
1.11
0.06
4.4
7.1
mmol/l
7.9
7.1
0.39
11
82
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
121
0.91
0.06
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
569
0.98
0.02
2.1
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
103
1.07
0.02
1.1
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
133
1.05
0.01
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
363
1.02
0.01
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
106
0.94
0.01
1.1
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
64
634
1.01
0.00
2.4
4.0
%
1.2
0.8
0.56
41
202
(3042631) Mycobacterium sp identified in Specimen
13
126
1.03
0.00
2.4
2.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
113
0.97
0.00
1.6
2.0
pg
31.1
32.2
0.22
11
113
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
121
0.99
0.00
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
333
0.99
0.00
1.8
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
57
567
1.01
0.00
2.6
3.9
%
0.7
0.5
0.30
32
147
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
105
1.05
0.00
1.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
105
1.05
0.00
1.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
105
0.95
0.00
1.1
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
105
0.95
0.00
1.1
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
77
0.91
0.00
1.0
1.9
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
2.0
—
2.3
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
384.8
—
0
5
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
50
1.00
0.00
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
1.0
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
50
1.00
0.00
1.2
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_PANCREAS_ADENO – Adenocarcinoma of pancreas

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).